Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 40, Issue 2, 2005, Pages 220-222

  Thayu, Meena ^a   Markowitz, Jonathan E ^a   Mamula, Petar ^a   Russo, Pierre A ^a   Muinos, William I ^b   Baldassano, Robert N ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; HYDROCORTISONE; INFLIXIMAB; LIVER ENZYME; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; PREDNISONE;

ADOLESCENT; ANUS FISTULA; ARTICLE; AUTOIMMUNE HEPATITIS; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; CASE REPORT; CROHN DISEASE; DIARRHEA; FEMALE; GROWTH DISORDER; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LIVER BIOPSY; PANCYTOPENIA; PRIORITY JOURNAL; SEPSIS; T CELL LYMPHOMA; WEIGHT REDUCTION;

6-MERCAPTOPURINE; ADOLESCENT; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FATAL OUTCOME; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER NEOPLASMS; LYMPHOMA, T-CELL; SPLENIC NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

FISTULA;

EID: 13944252969     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200502000-00026     Document Type: Article

References (19)

1. Greenstein AJ, Mullin GE, Strauchen JA, et al. Lymphoma in inflammatory bowel disease. Cancer Mar 1 1992;69:1119-23.
2. Greenstein AJ, Gennuso R, Sachar DB, et al. Extraintestinal cancers in inflammatory bowel disease. Cancer 1985;56:2914-21.
3. Gyde SN, Prior P, Macartney JC, Thompson H, Waterhouse JA, Allan RN. Malignancy in Crohn's disease. Gut 1980;21:1024-9.
4. Farcet JP, Gaulard P, Marolleau JP, et al. Hepatosplenic T-cell lymphoma: sinusal/sinusoidal localization of malignant cells expressing the T-cell receptor gamma delta. Blood 1990;75:2213-9.
5. Jaffe ES, Ralfkiaer E. Pathology and genetics of tumours of hematopoietic and lymphoid tissues: hepatosplenic T-cell lymphoma. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours Lyon: IARC Press; 2001: 210-1.
6. Dong J, Chong YY, Meyerson HJ. Hepatosplenic alpha beta T-cell lymphoma: a report of an S100-positive case. Arch Pathol Lab Med 2003;127:e119-22.
7. Shahab N, Kissenger RL, Malhotra V, Doll DC. Hematologic malignancies with extramedullary spread of disease. Case 2. Hepatosplenic T-cell lymphoma. J Clin Oncol 2003;21:1889-90.
8. Weidmann E. Hepatosplenic T cell lymphoma. A review on 45 cases since the first report describing the disease as a distinct lymphoma entity in 1990. Leukemia 2000;14:991-7.
9. Khan WA, Yu L, Eisenbrey AB, et al. Hepatosplenic gamma/delta T-cell lymphoma in immunocompromised patients. Report of two cases and review of literature. Am J Clin Pathol 2001;116:41-50.
10. Navarro JT, Ribera JM, Mate JL, et al. Hepatosplenic T-gamma delta lymphoma in a patient with Crohn's disease treated with azathioprine. Leuk Lymphoma 2003;44:531-3.
11. Lewis JD, Bilker WB, Brensinger C, et al. Inflammatory bowel disease is not associated with an increased risk of lymphoma. Gastroenterology 2001;121:1080-7.
12. Aithal GP, Mansfield JC. Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment. Aliment Pharmacol Ther 2001;15:1101-8.
13. Fraser AG, Orchard TR, Robinson EM, Jewell DP. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Aliment Pharmacol Ther 2002;16:1225-32.
14. Lewis JD, Schwartz JS, Lichtenstein GR. Azathioprine for maintenance of remission in Crohn's disease: benefits outweigh the risk of lymphoma. Gastroenterology 2000;118:1018-24.
15. Bickston SJ, Lichtenstein GR, Arseneau KO, Cohen RB, Cominelli F. The relationship between infliximab treatment and lymphoma in Crohn's disease. Gastroenterology 1999;117:1433-7.
16. Colombel JF, Loftus EV Jr, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patients. Gastroenterology 2004;126:19-31.
17. Hanauer SB, Feagan BG, Lichtenstein GR, et al. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002;359(9317):1541-9.
18. Daysharsh GA, Loftus EV, Sandborn WJ, et al. Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine. Gastroenterology 2002;122:72-7.
19. Reijasse D, Le Pendeven C, Cosnes J, et al. Epstein-Barr virus viral load in Crohn's disease: effect of immunosuppressive therapy. Inflamm Bowel Dis 2004;10:85-90.